Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Vertiv (VRT) Drops -20.5% Over 30 Days After Earnings Miss: Examining the AI Data Center Pullback

Vertiv (VRT) Drops -20.5% Over 30 Days After Earnings Miss: Examining the AI Data Center Pullback

Key Takeaways

  • Vertiv (VRT) shares tumbled approximately 20.5% over the last 30 days, driven primarily by a sharp post-earnings selloff on July 29 following a Q2 revenue miss.
  • The company beat adjusted EPS estimates ($1.52 vs. $1.43 consensus) and raised full-year 2026 guidance, yet investor focus locked onto the $110 million revenue shortfall and supply-chain execution concerns.
  • At least seven Wall Street analysts cut price targets after the report, though most retained Buy or Outperform ratings; the stock fell as much as 17% in a single session.
  • Over the broader quarter, VRT has declined roughly 28%, with the stock cooling from elevated valuations after a dramatic multi-year run tied to AI data center infrastructure demand.
  • Despite the selloff, underlying demand for power and cooling infrastructure remains robust, and the company's $15 billion backlog provides long-term revenue visibility.

Vertiv's Place in the AI Infrastructure Supply Chain

Vertiv Holdings Co designs, manufactures, and services critical digital infrastructure technologies for data centers, communication networks, and commercial and industrial environments worldwide. Its product portfolio spans AC and DC power management systems, thermal management and cooling solutions, switchgear, busbar, and integrated modular infrastructure. Vertiv has become one of the most closely watched pure-play stocks in the AI infrastructure boom, as its power and cooling systems are essential for the high-density compute environments required by next-generation AI workloads. The company's close partnership with NVIDIA (NVDA) on 800V DC power architectures and AI data center deployments further cements its strategic relevance. With a market capitalization above $90 billion, Vertiv is a dominant force in the data center infrastructure supply chain. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Price Action: 30-Day and Quarterly Moves

Over the last 30 days, VRT shares declined approximately 20.5%, falling from a closing price of $300.53 on July 2 to $238.82 as of early trading on August 3, 2026. The single largest catalyst was the July 29 Q2 earnings release, when the stock plunged roughly 17% intraday despite better-than-expected profitability and an upward revision to full-year guidance. The revenue miss of approximately $110 million against consensus triggered a swift repricing as investors reassessed execution risks. Over the broader quarter, the decline has been even steeper. From early May levels around $328–$330, VRT has shed roughly 28% of its value. The quarterly trend reflects a gradual cooling from elevated valuations, with the stock retreating from its 52-week high of $379.93 reached earlier in 2026. Even after the recent pullback, VRT remains up approximately 56% year-over-year, underscoring how far the stock rallied during the AI infrastructure buildout cycle. From what I see, this kind of volatility often follows periods of rapid appreciation.

Earnings Release and Immediate Market Response

The dominant event of the last 30 days was Vertiv's Q2 2026 earnings report on July 29. The company posted adjusted earnings of $1.52 per share, comfortably above the $1.43 consensus estimate, and raised its full-year 2026 guidance for organic sales growth, adjusted operating margin, and adjusted EPS. However, revenue of $3.27 billion missed analyst expectations of approximately $3.39 billion. CEO Giordano Albertazzi attributed the revenue timing gap to multi-phase project execution challenges and supply chain interdependencies — both internal and external — describing the issue as a learning curve associated with larger, more complex deployments rather than any weakening of underlying demand. The market reaction was swift and severe. At least seven analyst firms reduced price targets within hours of the report: Goldman Sachs moved from $352 to $301, RBC from $418 to $337, Citigroup from $414 to $358, and Bernstein from $416 to $368. Crucially, nearly all maintained Buy or Outperform ratings, signaling that the downgrades reflected recalibrated near-term expectations rather than a loss of conviction in Vertiv's market position. The selloff was amplified by the stock's elevated valuation multiples heading into the print — with forward P/E ratios above 45x — leaving little room for any disappointment. Additional pressure came from broader sector rotation and profit-taking after a year in which VRT had more than doubled from its 52-week low. I cross-referenced the reaction using Tickeron’s AI Daily Buy/Sell Signals for added context on sentiment shifts.

Quarterly Trends and Valuation Reset

Vertiv's quarterly decline reflects a broader reset in AI infrastructure names after a period of exceptional gains. The stock entered the quarter trading near $330, having already benefited from S&P 500 inclusion in March 2026 — a mechanical catalyst that drove forced buying by index funds rather than a reassessment of fundamentals. Through May and June, VRT experienced heightened volatility as institutional investors debated whether AI-driven growth rates could sustain the stock's premium valuation. The June period saw a sharp drop to near $276 before a recovery to around $358, followed by renewed selling into the July earnings event. Throughout the quarter, insider selling activity — with approximately $24 million in shares sold and zero insider purchases over a trailing three-month window — added a layer of caution for retail investors. While demand fundamentals for data center power and cooling infrastructure remained robust, the quarter demonstrated that even market-leading AI beneficiaries face scrutiny when valuations disconnect from near-term execution reality.

Forward Outlook and Key Monitors

Looking ahead, Vertiv's trajectory will depend heavily on execution against its raised full-year guidance, which now calls for $13.8 billion to $14.2 billion in net sales and adjusted EPS of $6.65 to $6.75. The Q3 2026 outlook — projecting revenue of $3.65 billion to $3.85 billion and adjusted operating margins of 24% to 25% — sets a high bar that management must meet to rebuild credibility on revenue delivery. Macroeconomic factors including tariff impacts, interest rate policy, and hyperscaler capital expenditure budgets remain key external variables. On the competitive front, Vertiv's ability to scale 800V DC power solutions in collaboration with NVIDIA could expand its addressable content per megawatt of data center capacity. The company's $15 billion order backlog and $5.6 billion liquidity position provide meaningful insulation, but investors will closely monitor whether supply chain bottlenecks flagged in Q2 prove transitory or persistent. Analyst consensus remains at Strong Buy with a mean price target near $344, implying significant potential upside from current levels — but only if revenue execution catches up with profitability momentum. One thing that stands out is how the $15 billion backlog continues to offer visibility even amid short-term noise.

Using Tickeron Tools in My Research Process

In my analysis of names like this, I often turn to Tickeron’s Trending AI Robots page for a quick look at top-performing automated strategies. It highlights bots that have shown strength across various timeframes and approaches, which helps me cross-check signals without replacing my own fundamental work. This resource has become a regular part of how I review market conditions before forming a fuller view.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VRT

VRT's RSI Oscillator recovers from oversold territory

The RSI Oscillator for VRT moved out of oversold territory on July 31, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where VRT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VRT just turned positive on August 06, 2026. Looking at past instances where VRT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRT advanced for three days, in of 354 cases, the price rose further within the following month. The odds of a continued upward trend are .

VRT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VRT as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

VRT moved below its 50-day moving average on July 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VRT entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.272) is normal, around the industry mean (8.806). P/E Ratio (62.256) is within average values for comparable stocks, (125.679). Projected Growth (PEG Ratio) (1.295) is also within normal values, averaging (1.368). Dividend Yield (0.001) settles around the average of (0.010) among similar stocks. P/S Ratio (9.398) is also within normal values, averaging (12.402).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.92B. The market cap for tickers in the group ranges from 457 to 300.34B. CYATY holds the highest valuation in this group at 300.34B. The lowest valued company is NXUR at 457.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was 7%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -10%. OESX experienced the highest price growth at 77%, while ELPW experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 71
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 82
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
VRT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the design, manufacturing, and servicing of critical digital infrastructure technology that powers, cools, deploys, secures and maintains electronics that process, store and transmit data.

Industry ElectricalProducts

Profile
Details
Industry
N/A
Address
505 North
Phone
+1 614 888-0246
Employees
27000
Web
https://www.vertiv.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.